Baudax Bio, Inc.
490 Lapp Rd.
Malvern, Pennsylvania 19355
September 21, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: | Baudax Bio, Inc. Registration Statement on Form S-1 (File No. 333-274349) |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Baudax Bio, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (File No. 333-274349) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 9:30 AM, eastern time, on September 25, 2023, or as soon as thereafter as is practicable.
Please contact Jennifer Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
Very truly yours, | ||||
BAUDAX BIO, INC. | ||||
By: | /s/ Gerri A. Henwood | |||
Name: | Gerri A. Henwood | |||
Title: | Chief Executive Officer |
Baudax Bio, Inc. — Acceleration Letter